TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22619616

Group type: EXPERIMENTAL
Intervention: 10 mmHg pressure pneumoperitoneum
Number of subjects: 43

Group type: COMPARATOR
Intervention: 14 mmHg pressure pneumoperitoneum
Number of subjects: 43
Study: 20690561

Group type: EXPERIMENTAL
Intervention: Pegylated interferon and ribavirin treatment
Number of subjects: 78
Study: 18444168

Group type: EXPERIMENTAL
Intervention: Lycopene supplementation (30 mg/day for 2 months)
Number of subjects: 60
Study: 16006090

Group type: EXPERIMENTAL
Intervention: Intravenous iron saccharate Venofer (5 mg/kg injection on day 1)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group without iron supplementation
Number of subjects: 93
Study: 14644797

Group type: EXPERIMENTAL
Intervention: Intraosseous access using Bone Injection Gun (BIG) while wearing protective gear
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intraosseous access using Bone Injection Gun (BIG) without protective gear
Number of subjects: 0
Study: 11049243

Group type: EXPERIMENTAL
Intervention: Ambroxol treatment (1,000 mg diluted in 500 ml of 5% glucose solution, given intravenously for 4 hours once a day for 3 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no ambroxol administered)
Number of subjects: 80
Study: 8795314

Group type: EXPERIMENTAL
Intervention: Pre-oxygenation (group 1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Hyperoxygenation (group 3)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No pre-oxygenation (group 2)
Number of subjects: 27
Study: 1618668

Group type: EXPERIMENTAL
Intervention: EBIORT
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: EBIORT plus ERT
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control
Number of subjects: 37
Study: 6712466

Group type: EXPERIMENTAL
Intervention: Dexamethasone sodium phosphate (6 mg/kg) over 48 hours
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no steroids)
Number of subjects: 48
Study: 30298202

Group type: EXPERIMENTAL
Intervention: tenofovir/emtricitabine + atazanavir/ritonavir (TDF/FTC + ATV/r)
Number of subjects: 293

Group type: COMPARATOR
Intervention: abacavir/lamivudine + atazanavir (ABC/3TC + ATV)
Number of subjects: 293
Study: 29947107

Group type: EXPERIMENTAL
Intervention: Resistance exercise only (RES)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Concurrent aerobic and resistance exercise (CEX)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Aerobic exercise only (AER)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-exercise control (CON)
Number of subjects: 84
Study: 27195809

Group type: EXPERIMENTAL
Intervention: IPV and the Workplace training
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (6 months delayed training)
Number of subjects: 27
Study: 24324004

Group type: EXPERIMENTAL
Intervention: Acute high altitude exposure (5050 m) in lowlanders
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Chronic high altitude exposure (days 12-14 at 5050 m) in lowlanders
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Highlanders at 5050 m
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normobaric hypoxic chamber exposure (F IO 2 = 0.11; 6 h) in lowlanders
Number of subjects: 24
Study: 22827728

Group type: EXPERIMENTAL
Intervention: Perineal massage during labor
Number of subjects: 396
Study: 19894061

Group type: EXPERIMENTAL
Intervention: MYA during PEG
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: MYA during STR
Number of subjects: 62

Group type: COMPARATOR
Intervention: CON during PEG
Number of subjects: 62

Group type: COMPARATOR
Intervention: CON during STR
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: MYA vs CON (microdialysis)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: NIRS (both groups during PEG)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: VAS score at rest
Number of subjects: 62
Study: 17011074

Group type: EXPERIMENTAL
Intervention: Spanish and English educational videos
Number of subjects: 107

Group type: COMPARATOR
Intervention: Routine discussion
Number of subjects: 107
Study: 16300166

Group type: EXPERIMENTAL
Intervention: EMD 87 580 (50 mg once daily) in patients with renal dysfunction (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: EMD 87 580 (100 mg twice daily) in patients with normal renal function (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EMD 87 580 (50 mg dose) in patients with renal dysfunction (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: EMD 87 580 (50 mg dose) in patients with normal renal function (Group 1)
Number of subjects: 30
Study: 11883375

Group type: EXPERIMENTAL
Intervention: 60% oxygen (oxygen group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: 21% oxygen (air group)
Number of subjects: 44
Study: 9845636

Group type: EXPERIMENTAL
Intervention: Stapled group (32 patients, 40 anastomoses) with functional end-to-end anastomoses made with linear staplers and circular stapling anastomoses.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Hand-sewn group (36 patients, 48 anastomoses) with anastomoses achieved by layer-to-layer suturing.
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both stapled and hand-sewn procedures.
Number of subjects: 68
Study: 7877298

Group type: EXPERIMENTAL
Intervention: Conversational recast language intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Imitative intervention
Number of subjects: 21
Study: 2508850

Group type: EXPERIMENTAL
Intervention: Interferon alfa (5-10 MU/m2 daily for 5 days, then 10 MU/m2 thrice weekly for 11 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 71
Study: 47083

Group type: EXPERIMENTAL
Intervention: Intradermal rabies vaccine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Intramuscular rabies vaccine
Number of subjects: 35
Study: 31845191

Group type: EXPERIMENTAL
Intervention: Activated micronutrients in support to the carbon cycle (Impryl, Parthenogen, Switzerland)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 32
Study: 31287021

Group type: EXPERIMENTAL
Intervention: PPIUD intervention
Number of subjects: 39084
Study: 28483015

Group type: EXPERIMENTAL
Intervention: Hemocoagulase agkistrodon (2 U) injected 20 minutes before surgery and 4 and 24 hours after surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 60
Study: 26260135

Group type: EXPERIMENTAL
Intervention: JOVEN/YOUTH: Juntos Opuestos a la Violence Entre Novios/Together Against Dating Violence
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (delayed condition)
Number of subjects: 82
Study: 24107878

Group type: EXPERIMENTAL
Intervention: Valdoxan
Number of subjects: 0
Study: 22137081

Group type: EXPERIMENTAL
Intervention: Resolute zotarolimus-DES (Medtronic CardioVascular)
Number of subjects: 2292

Group type: COMPARATOR
Intervention: Xience everolimus-DES (Abbott Vascular)
Number of subjects: 2292

Group type: EXPERIMENTAL
Intervention: Resolute zotarolimus-DES
Number of subjects: 2292

Group type: COMPARATOR
Intervention: Xience everolimus-DES
Number of subjects: 2292
Study: 19151284

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 52

Group type: COMPARATOR
Intervention: 4% lidocaine
Number of subjects: 52
Study: 16838426

Group type: EXPERIMENTAL
Intervention: Candesartan (target dose 32 mg once daily, mean dose 24 mg)
Number of subjects: 7601

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7601

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 7601
Study: 15316867

Group type: EXPERIMENTAL
Intervention: Alendronate (5.0 mg)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Alfacalcidol (1 microg)
Number of subjects: 170
Study: 11218056

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9481098

Group type: EXPERIMENTAL
Intervention: 0.2% w/w DEC‐medicated salt
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 18
Study: 1555751

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholate (600 mg/day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Untreated gallstone patients
Number of subjects: 37
Study: 4006240

Group type: EXPERIMENTAL
Intervention: Clonidine (transdermal therapeutic system) for 4 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Timolol (10-20 mg/d) for 6 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Methyldopa (250-500 mg/d) for 6 weeks
Number of subjects: 37
Study: 3312541

Group type: EXPERIMENTAL
Intervention: High-copper amalgam alloy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional lathe-cut amalgam alloy
Number of subjects: 0
Study: 30629782

Group type: EXPERIMENTAL
Intervention: Pain-related images
Number of subjects: 55

Group type: COMPARATOR
Intervention: Neutral images
Number of subjects: 55

Group type: COMPARATOR
Intervention: Threatening information condition
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-threatening information condition
Number of subjects: 55
Study: 27771425

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 151
Study: 25381348

Group type: EXPERIMENTAL
Intervention: Unilateral surgical nerve decompression at four sites in the lower extremity
Number of subjects: 39

Group type: COMPARATOR
Intervention: Contralateral limb (control)
Number of subjects: 39
Study: 24447017

Group type: EXPERIMENTAL
Intervention: Responsive Teaching (RT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard preschool classroom services
Number of subjects: 15
Study: 22025606

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 2201

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 2201
Study: 18454659

Group type: EXPERIMENTAL
Intervention: HCP sheets combined with PRP and HA
Number of subjects: 30

Group type: COMPARATOR
Intervention: PRP with HA
Number of subjects: 30
Study: 16545251

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (3500 IU/d of bemiparin) subcutaneously for 6 months
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no heparin prophylaxis)
Number of subjects: 87
Study: 12694124

Group type: EXPERIMENTAL
Intervention: Menotreat
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cavaterm
Number of subjects: 31

Group type: COMPARATOR
Intervention: Both methods
Number of subjects: 31
Study: 10757566

Group type: EXPERIMENTAL
Intervention: Normothermic cardiopulmonary bypass (NTCPB) at 36-37 degrees C
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hypothermic cardiopulmonary bypass (HTCPB) at 28 degrees C
Number of subjects: 36

Group type: COMPARATOR
Intervention: CABG patients without gross neurologic complications
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CABG patients with neurologic complications
Number of subjects: 36
Study: 8729673

Group type: EXPERIMENTAL
Intervention: Natural rubber latex proteins
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Banana proteins
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Banana skin-prick test
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Banana RAST
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Immunoblotting
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Symptoms from eating or handling bananas
Number of subjects: 22
Study: 1384845

Group type: EXPERIMENTAL
Intervention: 6% HES 200/0.6-0.66
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lactated Ringer's solution
Number of subjects: 12
Study: 2864158

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Carbimazole
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30577725

Group type: EXPERIMENTAL
Intervention: Hand hygiene curriculum
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Group handwashing station
Number of subjects: 95
Study: 30514048

Group type: EXPERIMENTAL
Intervention: Modified incision group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine incision group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 26772193

Group type: EXPERIMENTAL
Intervention: Synbiotic therapy
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Synbiotic therapy (in patients not receiving antibiotics)
Number of subjects: 37
Study: 24982917

Group type: EXPERIMENTAL
Intervention: 0.6 mg/ml levobupivacaine plus 2 mcg/ml fentanyl
Number of subjects: 80

Group type: COMPARATOR
Intervention: 1 mg/ml levobupivacaine
Number of subjects: 80
Study: 22905886

Group type: EXPERIMENTAL
Intervention: Early mobilization (EM) on post-operative day 2
Number of subjects: 50

Group type: COMPARATOR
Intervention: Late mobilization (LM) on post-operative day 7
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Early mobilization (EM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Late mobilization (LM)
Number of subjects: 50
Study: 20457157

Group type: EXPERIMENTAL
Intervention: Oral viscous budesonide (OVB) 1 mg for patients <5 feet tall and 2 mg for patients >=5 feet tall, daily for 3 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 18509786

Group type: EXPERIMENTAL
Intervention: Ibuprofen (n = 22)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Indomethacin (n = 24)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Pharmacological closure (NSAIDs treatment)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Failed pharmacological closure
Number of subjects: 46
Study: 16202594

Group type: EXPERIMENTAL
Intervention: Educational programme using cartoons, video-recording, print materials, and face-to-face educational methods
Number of subjects: 1131

Group type: COMPARATOR
Intervention: 2 hour lecture about schistosomiasis
Number of subjects: 1131
Study: 11897647

Group type: EXPERIMENTAL
Intervention: Treprostinil
Number of subjects: 470

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 470
Study: 9609358

Group type: EXPERIMENTAL
Intervention: Physiological mixed meal ingestion in Type 2 DM patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Physiological mixed meal ingestion in non-diabetic controls
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Type 2 DM patients
Number of subjects: 14
Study: 7891492

Group type: EXPERIMENTAL
Intervention: Meta-analysis of randomised controlled trials
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Meta-analysis demonstrating a protective effect from an intervention of more than 40%
Number of subjects: 185
Study: 2797920

Group type: EXPERIMENTAL
Intervention: Pressurized aerosol (2 mg terbutaline)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Turbuhaler (2 mg terbutaline)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Nebuhaler (1 mg terbutaline)
Number of subjects: 13
Study: 507256

Group type: EXPERIMENTAL
Intervention: 0.1 ml of bivalent split virus vaccine (A/New Jersey/76 and A/Victoria/75) intradermally
Number of subjects: 2

Group type: COMPARATOR
Intervention: 0.5 ml of bivalent split virus vaccine (A/New Jersey/76 and A/Victoria/75) subcutaneously
Number of subjects: 2
Study: 31586596

Group type: EXPERIMENTAL
Intervention: Self-compassion strategy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self-critical rumination
Number of subjects: 60
Study: 30297351

Group type: EXPERIMENTAL
Intervention: Marine protein hydrolysate (MPH) 3 g per day for 12 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27267603

Group type: EXPERIMENTAL
Intervention: Literacy-appropriate 'dirty bomb' decision aid
Number of subjects: 50

Group type: COMPARATOR
Intervention: CDC 'factsheet' (control)
Number of subjects: 50
Study: 25275318

Group type: EXPERIMENTAL
Intervention: Pro-inflammatory plasma markers and monocyte subsets in TB-IRIS patients pre-ART and at the time of IRIS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD14(++)CD16(-) monocytes frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Production of inflammatory cytokines by monocytes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pro-inflammatory biomarkers
Number of subjects: 0
Study: 21835513

Group type: EXPERIMENTAL
Intervention: Web-based peer review tool
Number of subjects: 20

Group type: COMPARATOR
Intervention: Paper-based peer review tool
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both tools
Number of subjects: 20
Study: 20682320

Group type: EXPERIMENTAL
Intervention: Budesonide (1 mg twice daily for 15 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17978591

Group type: EXPERIMENTAL
Intervention: Carvedilol 6.25 to 25 mg bid
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Metoprolol tartrate 50 to 200 mg bid
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Carvedilol and Metoprolol
Number of subjects: 1235

Group type: COMPARATOR
Intervention: Carvedilol vs Metoprolol
Number of subjects: 1235
Study: 15545661

Group type: COMPARATOR
Intervention: AC (adjuvant doxorubicin/cyclophosphamide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AC+T (adjuvant doxorubicin/cyclophosphamide followed by paclitaxel)
Number of subjects: 0
Study: 11933177

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by radiotherapy (CT + RT)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Radiotherapy alone (RT)
Number of subjects: 210
Study: 9627359

Group type: EXPERIMENTAL
Intervention: Insulin (I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sulfonylurea (SU)
Number of subjects: 20
Study: 8150016

Group type: EXPERIMENTAL
Intervention: Medium-titre Edmonston-Zagreb (EZ) measles vaccine (10(4.6) p.f.u.)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard Schwarz (SW) measles vaccine
Number of subjects: 75
Study: 2963054

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30940047

Group type: EXPERIMENTAL
Intervention: Mindful music listening
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Music listening
Number of subjects: 72

Group type: COMPARATOR
Intervention: Audiobook listening
Number of subjects: 72
Study: 29992584

Group type: EXPERIMENTAL
Intervention: rs12979860 TT genotype among HIV+ PWID
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: rs12979860 TT genotype
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Duration of intravenous drug use (IVDU)
Number of subjects: 345
Study: 26848570

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Omega-3 (700 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitamins E + C (235 mg + 1 g)
Number of subjects: 50
Study: 26472571

Group type: EXPERIMENTAL
Intervention: Energy restriction group (ERG) following an energy-restricted diet of -3347.2 kJ/d (-800 kcal/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (CG) advised not to change their food intake
Number of subjects: 21
Study: 22078985

Group type: EXPERIMENTAL
Intervention: Aerobic Continuous Training (ACT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study: 22042277

Group type: EXPERIMENTAL
Intervention: PEG-L-asparaginase (2500 IU/m/dose intramuscularly on days 1 and 15)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Native E. coli asparaginase (10,000 IU/m/dose intramuscularly on days 1, 3, 5, 8, 10, 12, 15, 17, 19, 22, 24, and 26)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: PEG-L-asparaginase
Number of subjects: 76
Study: 18628693

Group type: EXPERIMENTAL
Intervention: Physiotherapy with postural biofeedback
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 47
Study: 16409194

Group type: EXPERIMENTAL
Intervention: Grass allergen tablets (75,000 SQ‐T)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 14531956

Group type: EXPERIMENTAL
Intervention: Disease-modifying antirheumatic drugs (DMARDs), specific types and dosages not mentioned, focus on effective treatment for RA.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11028795

Group type: EXPERIMENTAL
Intervention: Supervised outpatient-group training programme, 50 min three times a week for 3 months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 9201809

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 7997902

Group type: EXPERIMENTAL
Intervention: promethazine 0.5 mg/kg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: metoclopramide 0.2 mg/kg
Number of subjects: 32

Group type: COMPARATOR
Intervention: isotonic saline
Number of subjects: 32
Study: 3395401

Group type: EXPERIMENTAL
Intervention: Vadocaine hydrochloride 15 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Vadocaine hydrochloride (5, 10, 15, 20, 30, 50 mg)
Number of subjects: 6
Study: 31869817

Group type: EXPERIMENTAL
Intervention: TMR® FAB 6-treatment protocol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 30761498

Group type: EXPERIMENTAL
Intervention: Contaminated group (exposed to BTEX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not exposed to BTEX)
Number of subjects: 0
Study: 29117576

Group type: EXPERIMENTAL
Intervention: Anti-Müllerian hormone (AMH) assay
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: AMH measured at end of chemotherapy
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Follicle-stimulating hormone (FSH)
Number of subjects: 73
Study: 24626819

Group type: EXPERIMENTAL
Intervention: 400 mg/d of algal docosahexaenoic acid (DHA)
Number of subjects: 869

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 869
Study: 22656403

Group type: EXPERIMENTAL
Intervention: Telephone consultations from pharmacists regarding asthma self-management over a 3-month period
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 98
Study: 20149235

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 552